Literature DB >> 31385962

Core deficits and quality of survival after childhood medulloblastoma: a review.

Mathilde Chevignard1, Hugo Câmara-Costa1, François Doz1, Georges Dellatolas1.   

Abstract

BACKGROUND: Medulloblastoma is the most common malignant central nervous system tumor in children. Treatment most often includes surgical resection, craniospinal irradiation, and adjuvant chemotherapy. Although survival has improved dramatically, the tumor and its treatments have devastating long-term side effects that negatively impact quality of survival (QoS). The objective was to review the literature on QoS following childhood medulloblastoma.
METHODS: This narrative review is based on a Medline database search and examination of the reference lists of papers selected.
RESULTS: Frequent problems after medulloblastoma treatment include medical complications, such as long-term neurological and sensory (hearing loss) impairments; endocrine deficits, including growth problems; and secondary tumors. Neurocognitive impairment is repeatedly reported, with decreasing cognitive performances over time. Although all cognitive domains may be affected, low processing speed, attention difficulties, and working memory difficulties are described as the core cognitive deficits resulting from both cerebellar damage and the negative effect of radiation on white matter development. Long-term psychosocial limitations include low academic achievement, unemployment, and poor community integration with social isolation. Important negative prognostic factors include young age at diagnosis, conventional craniospinal radiotherapy, presence of postoperative cerebellar mutism, and perioperative complications. The influence of environmental factors, such as family background and interventions, remains understudied.
CONCLUSION: Future studies should focus on the respective impact of radiation, cerebellar damage, genomic and molecular subgroup parameters, and environmental factors on cognitive and psychosocial outcomes. Long-term (probably lifelong) follow-up into adulthood is required in order to monitor development and implement timely, suitable, multi-disciplinary rehabilitation interventions and special education or support when necessary.

Entities:  

Keywords:  medulloblastoma; neurocognitive deficit; psychosocial outcome; quality of life.; quality of survival

Year:  2016        PMID: 31385962      PMCID: PMC6655396          DOI: 10.1093/nop/npw013

Source DB:  PubMed          Journal:  Neurooncol Pract        ISSN: 2054-2577


  146 in total

1.  Patterns of neuropsychological deficits in children with medulloblastoma according to craniospatial irradiation doses.

Authors:  V Kieffer-Renaux; C Bulteau; J Grill; C Kalifa; D Viguier; I Jambaque
Journal:  Dev Med Child Neurol       Date:  2000-11       Impact factor: 5.449

2.  Neuropsychological consequences of cerebellar tumour resection in children: cerebellar cognitive affective syndrome in a paediatric population.

Authors:  L Levisohn; A Cronin-Golomb; J D Schmahmann
Journal:  Brain       Date:  2000-05       Impact factor: 13.501

3.  The cerebellum contributes to higher functions during development: evidence from a series of children surgically treated for posterior fossa tumours.

Authors:  D Riva; C Giorgi
Journal:  Brain       Date:  2000-05       Impact factor: 13.501

4.  Patterns of intellectual development among survivors of pediatric medulloblastoma: a longitudinal analysis.

Authors:  S L Palmer; O Goloubeva; W E Reddick; J O Glass; A Gajjar; L Kun; T E Merchant; R K Mulhern
Journal:  J Clin Oncol       Date:  2001-04-15       Impact factor: 44.544

5.  Ophthalmic complications of childhood medulloblastoma.

Authors:  L Cassidy; R Stirling; K May; S Picton; R Doran
Journal:  Med Pediatr Oncol       Date:  2000-01

6.  Risks of young age for selected neurocognitive deficits in medulloblastoma are associated with white matter loss.

Authors:  R K Mulhern; S L Palmer; W E Reddick; J O Glass; L E Kun; J Taylor; J Langston; A Gajjar
Journal:  J Clin Oncol       Date:  2001-01-15       Impact factor: 44.544

7.  Survival and neurodevelopmental outcome of young children with medulloblastoma at St Jude Children's Research Hospital.

Authors:  A W Walter; R K Mulhern; A Gajjar; R L Heideman; D Reardon; R A Sanford; X Xiong; L E Kun
Journal:  J Clin Oncol       Date:  1999-12       Impact factor: 44.544

8.  Neurocognitive deficits in medulloblastoma survivors and white matter loss.

Authors:  R K Mulhern; W E Reddick; S L Palmer; J O Glass; T D Elkin; L E Kun; J Taylor; J Langston; A Gajjar
Journal:  Ann Neurol       Date:  1999-12       Impact factor: 10.422

Review 9.  Neurocognitive development of children after a cerebellar tumor in infancy: A longitudinal study.

Authors:  D R Copeland; C deMoor; B D Moore; J L Ater
Journal:  J Clin Oncol       Date:  1999-11       Impact factor: 44.544

10.  Long-term intellectual outcome in children with posterior fossa tumors according to radiation doses and volumes.

Authors:  J Grill; V K Renaux; C Bulteau; D Viguier; C Levy-Piebois; C Sainte-Rose; G Dellatolas; M A Raquin; I Jambaqué; C Kalifa
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-08-01       Impact factor: 7.038

View more
  8 in total

1.  Neurocognitive function and survival in children with average-risk medulloblastoma treated with hyperfractionated radiation therapy alone: Long-term mature outcomes of a prospective study.

Authors:  Tejpal Gupta; Babusha Kalra; Savita Goswami; Jayita Deodhar; Pallavi Rane; Sridhar Epari; Aliasgar Moiyadi; Archya Dasgupta; Abhishek Chatterjee; Girish Chinnaswamy
Journal:  Neurooncol Pract       Date:  2022-03-13

Review 2.  Coming in from the cold: overcoming the hostile immune microenvironment of medulloblastoma.

Authors:  Tanja Eisemann; Robert J Wechsler-Reya
Journal:  Genes Dev       Date:  2022-05-01       Impact factor: 12.890

Review 3.  Cognitive Risk in Survivors of Pediatric Brain Tumors.

Authors:  Ade Oyefiade; Iris Paltin; Cinzia R De Luca; Kristina K Hardy; David R Grosshans; Murali Chintagumpala; Donald J Mabbott; Lisa S Kahalley
Journal:  J Clin Oncol       Date:  2021-04-22       Impact factor: 50.717

4.  Neurocognitive functioning and health-related quality of life in adult medulloblastoma patients: long-term outcomes of the NOA-07 study.

Authors:  Linda Dirven; Ralf Luerding; Dagmar Beier; Elisabeth Bumes; Christiane Reinert; Clemens Seidel; Matteo Mario Bonsanto; Michael Bremer; Stefan Rieken; Stephanie E Combs; Ulrich Herrlinger; Corinna Seliger; Holger Kuntze; Regine Mayer-Steinacker; Annette Dieing; Claudius Bartels; Oliver Schnell; Astrid Weyerbrock; Sabine Seidel; Oliver Grauer; Minou Nadji-Ohl; Frank Paulsen; Michael Weller; Wolfgang Wick; Peter Hau
Journal:  J Neurooncol       Date:  2020-05-04       Impact factor: 4.130

5.  Resection of cerebellar tumours causes widespread and functionally relevant white matter impairments.

Authors:  Carlos Alexandre Gomes; Katharina M Steiner; Nicolas Ludolph; Tamas Spisak; Thomas M Ernst; Oliver Mueller; Sophia L Göricke; Franziska Labrenz; Winfried Ilg; Nikolai Axmacher; Dagmar Timmann
Journal:  Hum Brain Mapp       Date:  2021-01-07       Impact factor: 5.038

Review 6.  Hedgehog Pathway Inhibitors against Tumor Microenvironment.

Authors:  Silpa Gampala; Jer-Yen Yang
Journal:  Cells       Date:  2021-11-12       Impact factor: 6.600

7.  Improved prediction of postoperative pediatric cerebellar mutism syndrome using an artificial neural network.

Authors:  Jai Sidpra; Adam P Marcus; Ulrike Löbel; Sebastian M Toescu; Derek Yecies; Gerald Grant; Kristen Yeom; David M Mirsky; Hani J Marcus; Kristian Aquilina; Kshitij Mankad
Journal:  Neurooncol Adv       Date:  2022-01-10

Review 8.  Educational Pain Points for Pediatric Brain Tumor Survivors: Review of Risks and Remedies.

Authors:  Peter L Stavinoha; Thuy Trinh-Wong; Laura N Rodriguez; Chawncey M Stewart; Kris Frost
Journal:  Children (Basel)       Date:  2021-12-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.